A. Hoffmann et al., Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: Acomparison between hypoxia and inhibitors of cell metabolism, J CELL PHYS, 188(1), 2001, pp. 33-44
Several papers report a hypoxia-induced upregulation of the endothelial nit
ric oxide synthase (eNOS) mRNA expression. Since there is no known hypoxia-
sensitive element binding site in the eNOS promoter, we reasoned that the e
ffect of hypoxia could be simulated by a metabolically elicited alteration
of the redox state. Therefore, cultured porcine aortic endothelial cells (P
AEC) were exposed to hypoxia (1-10% O-2) Or inhibitors of cellular energy m
etabolism including rotenone, 2, 4 dinitrophenol (DNP) and 2-deoxyglucose f
or 6 to 24 h. Additionally, cells were treated with lactate and nicotinic a
cid to alter the cellular NAD(P)H/NAD(P) ratio without changes of energy su
pply. The cellular NAD(P)H/NAD(P) ratio was used as an index of the cellula
r redox state and determined using the MTT-assay. Hypoxia increased eNOS mR
NA transcription and MTT-reduction in a manner inversely proportional to pO
(2). Exposure to rotenone, DNP, and lactate increased the NAD(P)H/NAD(P) ra
tio, MTT-reduction, and eNOS mRNA also in parallel. In contrast, 2-deoxyglu
cose and nicotinic acid attenuated both MTT-reduction and eNOS mRNA express
ion. In order to study a potential role of the redox regulated transcriptio
n factor complex AP-1 in hypoxia-induced eNOS mRNA transcription, c-jun exp
ression was determined and decoy experiments were performed. c-jun expressi
on paralleled changes of eNOS mRNA expression and MTT-reduction. Furthermor
e, in the presence of oligodeoxynucleotides corresponding to the AP-1 bindi
ng sites of the eNOS promoter, the hypoxia and chemically induced eNOS mRNA
expression was completely abolished. We propose that hypoxia, by altering
cellular metabolism, leads to an increase in the cellular NAD(P)H/NAD(P) ra
tio which favors enhanced eNOS expression by redox-sensitive AP-1 mediated
transcriptional control. (C) 2001 Wiley-Liss, Inc.